|
POLE2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
6.73289999975069E-07 |
| Normal-vs-Stage3 |
8.87849999964274E-07 |
| Normal-vs-Stage4 |
1.0523000248952E-09 |
| Stage1-vs-Stage2 |
2.245200E-01 |
| Stage1-vs-Stage3 |
9.743000E-01 |
| Stage1-vs-Stage4 |
5.723700E-02 |
| Stage2-vs-Stage3 |
3.943200E-01 |
| Stage2-vs-Stage4 |
1.477550E-02 |
| Stage3-vs-Stage4 |
1.563630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.23870000001691E-06 |
| Normal-vs-Asian |
2.15569999999499E-05 |
| Caucasian-vs-AfricanAmerican |
7.565600E-01 |
| Caucasian-vs-Asian |
7.437600E-01 |
| AfricanAmerican-vs-Asian |
6.198200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
6.66133814775094E-16 |
| Male-vs-Female |
8.643000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.20430000003247E-06 |
| Normal-vs-Age(41-60Yrs) |
6.23057161419638E-13 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.517450E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.594600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.205200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.010200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.536400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.919000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.832400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.74700000021843E-07 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.96760385762218E-11 |
| Normal-vs-Grade 4 |
1.35069999962489E-07 |
| Grade 1-vs-Grade 2 |
4.397000E-01 |
| Grade 1-vs-Grade 3 |
5.498000E-01 |
| Grade 1-vs-Grade 4 |
7.383400E-01 |
| Grade 2-vs-Grade 3 |
7.328200E-01 |
| Grade 2-vs-Grade 4 |
1.660560E-01 |
| Grade 3-vs-Grade 4 |
2.642600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62581059726108E-12 |
| Normal-vs-ccB subtype |
9.60519996873188E-10 |
| ccA subtype-vs-ccB subtype |
2.979800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71729297449019E-12 |
| Normal-vs-N1 |
2.718600E-03 |
| N0-vs-N1 |
7.158000E-01 |
|
|
